Imaging Team

Expertise

AI in Neurological Clinical Trials: Strategic Insights from John E. Kelly III, PhD

IBM Watson pioneer Dr. John E. Kelly III shares his perspective on AI adoption barriers, data quality, and the future of AI-enabled neurological...

Multiple Sclerosis

The New McDonald Criteria: Is Your MS Study Ready?

Discover how the new McDonald criteria use imaging biomarkers such as the Central Vein Sign (CVS) to make earlier, more accurate MS diagnosis

Press Release

Alzamend Neuro Partners with QMENTA, to Advance AI-Powered Imaging for its Phase II Clinical Trial of AL001 Study to Take Place at Massachusetts General Hospital

Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and...

Expertise

Top 5 Trends in Neuroscience You Need to Know in 2022

The neuro tech field has sped up in recent years and staying on top of trends is becoming a must in the neuro research. Choosing the right tech when...